FX.co ★ GE HealthCare Invests $138 Mln In Ireland To Meet Growing Demand For Contrast Media

GE HealthCare Technologies Inc. (GEHC) announced a significant investment of $138 million on Friday to enhance its Carrigtwohill, Cork contrast media fill and finish manufacturing site in Ireland. This expansion aims to produce an additional 25 million patient doses of contrast media annually by the end of 2027.

The new development involves constructing a 3,000 square meter facility, which will support both current and upcoming product lines. Engineering firm IPS-Integrated Project Services will spearhead the project, with construction at the Carrigtwohill site beginning in February.

Contrast media are critical injectable agents used in diagnostic imaging to improve the clarity of organs, blood vessels, and tissues for medical examinations.

In 2024, the Carrigtwohill facility, alongside GE HealthCare's production sites in Shanghai and Oslo, delivered over 100 million patient doses of contrast media.

Global demand for iodine-based contrast media, essential for X-rays, computed tomography, and interventional procedures, is projected to double over the next decade. This surge is attributed to aging populations and the rising global incidence of chronic illnesses.